文献速递甲状腺疾病性腺与生殖内分泌

甲状腺功能而非甲状腺抗体影响妊娠与围产结局:一项前瞻性研究结果

Thyroid Function Rather Than Thyroid Antibodies Affects Pregnancy and Perinatal Outcomes: Results of a Prospective Study.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

这项前瞻性研究在比萨医院内分泌科纳入2012至2021年间975例孕妇,其中572例(59%)诊断为自身免疫性甲状腺疾病,403例(41%)为对照;自身免疫性甲状腺疾病组在TSH>2.5 mIU/L、对照组在TSH>4 mIU/L时开始左甲状腺素治疗。结果显示,自身免疫性甲状腺疾病组流产率为4.8%,对照组为2.9%,两组无显著差异(P=0.181);在甲状腺功能得到严格控制的前提下,甲状腺自身抗体的存在及滴度不负面影响妊娠,但甲状腺激素状态欠佳似乎比甲状腺自身免疫对妊娠结局影响更大。

要点

  • 自身免疫性甲状腺疾病组流产率4.8%,对照组2.9%,两组无显著差异(P=0.181)。
  • 两组其他妊娠并发症无差异,未见与甲状腺抗体滴度相关的关联。
  • 在甲状腺功能严格控制下,TSH>4 mIU/L者流产与早产有增多趋势但未达显著。

核心结论

  • 若甲状腺功能得到充分控制,甲状腺自身抗体的存在及滴度不负面影响妊娠。
  • 尽管未达统计学显著,甲状腺激素状态欠佳似乎比甲状腺自身免疫对妊娠结局影响更大。

研究设计与样本

  • 前瞻性研究,于比萨医院内分泌科开展,研究时间为2012年至2021年。
  • 共纳入975例孕妇,572例(59%)诊断为自身免疫性甲状腺疾病(AT),403例(41%)为对照。
  • AT组TSH>2.5 mIU/L时开始左甲状腺素(LT4)治疗,对照组TSH>4 mIU/L时开始LT4治疗。

主要发现

  • AT组流产频率为4.8%,对照组为2.9%,两组无显著差异(P=0.181)。
  • 两组其他妊娠并发症无差异,未观察到与甲状腺抗体滴度的关联。
  • AT组先天性畸形频率高于对照组(P=0.019),但未发现与主要先天性畸形的相关性(P=0.872)。
  • 在甲状腺激素浓度被严格控制的人群中,TSH>4 mIU/L的妇女流产和早产有增多趋势但未达统计学显著。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Thyroid autoantibody positivity has been associated with an increased rate of obstetrical complications. OBJECTIVE: We aimed to evaluate the role of thyroid autoantibodies in adverse pregnancy outcomes. METHODS: This prospective study was conducted in the Endocrinology Unit of Pisa Hospital. A total of 975 pregnant women were studied from 2012 to 2021; 572 (59%) were diagnosed with autoimmune thyroid (AT) diseases; 403 (41%) served as controls. Levothyroxine (LT4) treatment was introduced when TSH was > 2.5 mIU/L in the AT group and when TSH was > 4 mIU/L in the controls. Rates of obstetrical complications in each group were measured. RESULTS: Although the frequency of miscarriage in the AT group was greater (4.8%) than in the controls (2.9%), no significant differences were detected (P = 0.181). There were no differences between the 2 groups concerning the other pregnancy complications, and no association with the titer of thyroid antibodies was observed. The frequency of congenital malformations was greater in the AT group than in the controls (P = 0.019), but no correlation with major congenital malformations was detected (P = 0.872). Given that thyroid hormone concentrations were strictly controlled in our population, we documented a tendency (not significant) toward an increase in miscarriage and preterm birth among women with TSH > 4 mIU/L. CONCLUSION: If thyroid function is adequately controlled, the presence and titer of thyroid autoantibodies does not negatively influence gestation. Although not significant, suboptimal thyroid hormone status seems to affect pregnancy outcomes more than thyroid autoimmunity.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Orsolini F, Gianetti E, Terrenzio C, et al. Thyroid Function Rather Than Thyroid Antibodies Affects Pregnancy and Perinatal Outcomes: Results of a Prospective Study. J Clin Endocrinol Metab. 2022. PMID: 36054923. doi:10.1210/clinem/dgac497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。